Kamlesh K Yadav Selected Research

Kamlesh K Yadav Research Topics

8	Neoplasms (Cancer) 05/2024 - 01/2016
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2023
2	Inflammation (Inflammations) 05/2022 - 01/2021
1	Carcinogenesis 12/2023
1	Neoplasm Metastasis (Metastasis) 12/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2023
1	Genomic Instability 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Carcinoma (Carcinomatosis) 01/2019
1	Disease Progression 01/2019
1	Adenocarcinoma 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2009
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2007

3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	Peptides (Polypeptides)IBA 12/2023 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2019
2	PseudouridineIBA 01/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2019 - 12/2018
2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2016
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 01/2017
1	UbiquitinIBA 12/2023
1	Oncogene Proteins (Oncogene Protein)IBA 12/2023
1	Proteasome InhibitorsIBA 12/2023
1	Conditioned Culture MediaIBA 05/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	CytokinesIBA 05/2022
1	Interleukin-33IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	LigandsIBA 01/2021
1	NucleosidesIBA 01/2021
1	NucleotidesIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	OligonucleotidesIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 06/2017
1	AndrogensIBA 06/2017
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2009
1	Heavy MetalsIBA 08/2009
1	Mitogen-Activated Protein KinasesIBA 01/2007
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2007

6	Therapeutics 05/2024 - 01/2016
2	Prostatectomy (Retropubic Prostatectomy) 05/2022 - 01/2019
1	Time-to-Treatment 01/2021
1	Castration 06/2017
1	Immunotherapy 01/2016